Journal articleBiofactors2020
Skullcapflavone I has a potent anti-pancreatic cancer activity by targeting miR-23a.
- Journal
- Biofactors
- Published
- 6 March 2020
- Citations
- 6
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Baicalein has been widely studied and showed a potent activity against pancreatic cancer in both in vivo and in vitro studies. Little is known regarding the effects of Skullcapflavone I (SFI), despite they have similar structures. … Excerpt only: this text is the publisher’s. Read it in full at the source.